{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:06:59Z","timestamp":1788887219679,"version":"build-2803163510"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560890"],"award-info":[{"award-number":["82560890"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012547","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2023GXNSFAA026316"],"award-info":[{"award-number":["2023GXNSFAA026316"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Commission of Guangxi Zhuang Autonomous Region","award":["Z-K20241721"],"award-info":[{"award-number":["Z-K20241721"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by persistent pain and a significant decline in quality of life. Tetrandrine (Tet), a bisbenzylisoquinoline alkaloid, exhibits significant antipyretic, analgesic, and anti-inflammatory effects. However, its low solubility in water limits its clinical applications. Objective: This study focuses on the preparation of tetrandrine nanocrystals (Tet-NCs) using ultrasound technology and evaluates their therapeutic effects and potential mechanisms in a rat model of adjuvant arthritis (AA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The AA model was induced using Freund\u2019s complete adjuvant (FCA). Tet-NCs were prepared via ultrasound technology and administered at varying doses. The efficacy of Tet-NCs was compared with that of Tet tablets and indomethacin tablets. The assessed outcomes include joint swelling, arthritis scores, pathological changes in the joints, levels of inflammatory factors (interleukin-6, interleukin-1\u03b2, tumor necrosis factor-\u03b1, prostaglandin E2, cyclooxygenase-2, vascular endothelial growth factor A, and matrix metalloproteinase-3) in joint cavities and serum, as well as the angiogenesis in synovial tissues and the expression of key proteins\u2014Janus kinase 1 (JAK1) and signal transducer and activator of transcription 3 (STAT3).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key findings<\/jats:title>\n                    <jats:p>Experimental data indicate that the average particle size of the optimized Tet-NCs is 124.30\u00a0nm, with a polydispersity index (PDI) of 0.27. The therapeutic effects of low-dose Tet-NCs were comparable to those of Tet tablets, while medium- and high-dose Tet-NCs were significantly more effective than Tet tablets in reducing ankle joint swelling, lowering inflammatory factors levels, and protecting joint structure, and showed no statistically significant difference from indomethacin under the tested conditions. Furthermore, the expression levels of JAK1 and STAT3 in the AA model were significantly reduced by both medium- and high-dose Tet-NCs (all P\u2009&amp;lt;\u2009.001).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates that Tet-NCs provide superior therapeutic effects in RA compared to conventional Tet tablets, and their mechanism of action may involve the regulation of inflammation through inhibition of the JAK1\/STAT3 signaling pathway. Consequently, Tet-NCs show potential for further development as a novel anti-arthritic agent, although their clinical applicability remains to be validated in future studies. Clinical trial number: not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jpp\/rgag083","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:36:57Z","timestamp":1784633817000},"source":"Crossref","is-referenced-by-count":0,"title":["Tetrandrine nanocrystals for rheumatoid arthritis: enhanced therapeutic efficacy associated with reduced JAK1 and STAT3 expression"],"prefix":"10.1093","volume":"78","author":[{"given":"Guangzhao","family":"Wang","sequence":"first","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University , Nanning, Guangxi 530000 ,","place":["China"]},{"name":"Pharmacy Department, The Sixth Affiliated Hospital of Guangxi Medical University (The First People's Hospital of Yulin) , Yulin 537000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Mo","sequence":"additional","affiliation":[{"name":"Interventional Ultrasound Department, The Sixth Affiliated Hospital of Guangxi Medical University (The First People's Hospital of Yulin) , Yulin 537000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiu","family":"Huang","sequence":"additional","affiliation":[{"name":"Guangdong Institute of Arts and Sciences , Zhanjiang, Guangdong 524000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhen","family":"Feng","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University , Nanning, Guangxi 530000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyi","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University , Nanning, Guangxi 530000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University , Nanning, Guangxi 530000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[{"name":"Pharmacy Department, The Sixth Affiliated Hospital of Guangxi Medical University (The First People's Hospital of Yulin) , Yulin 537000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University , Nanning, Guangxi 530000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyi","family":"Meng","sequence":"additional","affiliation":[{"name":"Pharmacy Department, The Sixth Affiliated Hospital of Guangxi Medical University (The First People's Hospital of Yulin) , Yulin 537000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4779-0807","authenticated-orcid":false,"given":"Xingzhen","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Guangxi Medical University , Nanning, Guangxi 530000 ,","place":["China"]},{"name":"Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation , Nanning, Guangxi 530000 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"2026090812140220800_ref1","first-page":"347","article-title":"One year in review 2019: pathogenesis of rheumatoid arthritis","volume":"37","author":"Croia","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"2026090812140220800_ref2","doi-asserted-by":"publisher","first-page":"Itc1","DOI":"10.7326\/AITC201901010","article-title":"Arthritis","volume":"170","author":"Rheumatoid","year":"2019","journal-title":"Ann Intern Med"},{"key":"2026090812140220800_ref3","first-page":"1059","article-title":"Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis","volume":"63","author":"National Clinical Research Center for Dermatologic and Immunologic Diseases (Peking Union Medical College Hospital); Chinese Association of Rheumatology and Immunology Physicians; Rheumatology and Immunology Professional Committee of Chinese Rehabilitation Medical Association; Rheumatology and Immunology Professional Committee of Chinese Research Hospital Association; Rheumatology and Immunology Branch of Beijing Association of Holistic Integrative Medicine","year":"2024","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2026090812140220800_ref4","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1001\/jama.2022.0786","article-title":"What is Rheumatoid arthritis?","volume":"327","author":"Smith","year":"2022","journal-title":"Jama"},{"key":"2026090812140220800_ref5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/08923973.2015.1125917","article-title":"Old and new therapeutics for Rheumatoid arthritis: in vivo models and drug development","volume":"38","author":"Sardar","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2026090812140220800_ref6","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"2026090812140220800_ref7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 203 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026090812140220800_ref8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/157339711794474620","article-title":"Choice of biologic therapy for patients with Rheumatoid arthritis: the infection perspective","volume":"7","author":"Keyser","year":"2011","journal-title":"Curr Rheumatol Rev"},{"key":"2026090812140220800_ref9","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/jor.23155","article-title":"Tetrandrine suppresses articular inflammatory response by inhibiting pro-inflammatory factors via NF-\u03baB inactivation","volume":"34","author":"Gao","year":"2016","journal-title":"J Orthop Res"},{"key":"2026090812140220800_ref10","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.3892\/etm.2018.6498","article-title":"Tetrandrine alleviates symptoms of rheumatoid arthritis in rats by regulating the expression of cyclooxygenase-2 and inflammatory factors","volume":"16","author":"Li","year":"2018","journal-title":"Exp Ther Med"},{"key":"2026090812140220800_ref11","volume-title":"Microneedles-Mediated Transdermal Administration of Tetrandrine-Loaded PLGA Nanoparticles for Treating Arthritis [D]","author":"Hu","year":"2020"},{"key":"2026090812140220800_ref12","first-page":"506","article-title":"Preparation and quality evaluation of tetrandrine nanocrystals","volume":"39","author":"Huang","year":"2022","journal-title":"J Guangxi Med Univ"},{"key":"2026090812140220800_ref13","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28176370","article-title":"Herbal medicine nanocrystals: A potential novel therapeutic strategy","volume":"28","author":"Guo","year":"2023","journal-title":"Molecules"},{"key":"2026090812140220800_ref14","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.2147\/IJN.S379736","article-title":"Study on integrated pharmacokinetics of the component-based Chinese medicine of Ginkgo biloba leaves based on nanocrystalline solid dispersion technology","volume":"17","author":"Liang","year":"2022","journal-title":"Int J Nanomedicine"},{"key":"2026090812140220800_ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20204990","article-title":"Solid nanocrystals of Rebamipide promote recovery from indomethacin-induced gastrointestinal bleeding","volume":"20","author":"Nagai","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026090812140220800_ref16","doi-asserted-by":"publisher","first-page":"108793","DOI":"10.1016\/j.clim.2021.108793","article-title":"Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis","volume":"230","author":"Liu","year":"2021","journal-title":"Clin Immunol"},{"key":"2026090812140220800_ref38","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1080\/14656566.2016.1241237","article-title":"Chemical JAK inhibitors for the treatment of rheumatoid arthritis","volume":"17","author":"Nakayamada","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"2026090812140220800_ref17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/1759720X18776224","article-title":"The role of the JAK\/STAT signal pathway in rheumatoid arthritis","volume":"10","author":"Malemud","year":"2018","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2026090812140220800_ref18","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.clinthera.2014.06.018","article-title":"Systematic review of tofacitinib: A new drug for the management of rheumatoid arthritis","volume":"36","author":"Kaur","year":"2014","journal-title":"Clin Ther"},{"key":"2026090812140220800_ref19","first-page":"725","article-title":"Mechanism of tetrandrine on improving synovial angiogenesis in rats with adjuvant arthritis based on JAK pathway","volume":"29","author":"Fan","year":"2018","journal-title":"Trad Chin Drug Res Clin Pharmacol"},{"key":"2026090812140220800_ref20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jor.23262","article-title":"Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes","volume":"35","author":"Haseeb","year":"2017","journal-title":"J Orthop Res"},{"key":"2026090812140220800_ref21","volume-title":"Study on the Mechanism of Tetrandrine in the Treatment of Rheumatoid Arthritis by Regulating Neutrophil Activity [D]","author":"Lu","year":"2020"},{"key":"2026090812140220800_ref22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10787-019-00642-0","article-title":"Anti-arthritic activity of ferulic acid in complete Freund\u2019s adjuvant (CFA)-induced arthritis in rats: JAK2 inhibition","volume":"28","author":"Zhu","year":"2019","journal-title":"Inflammopharmacology"},{"key":"2026090812140220800_ref23","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1096\/fj.201701148RR","article-title":"Tetrandrine attenuates the bone erosion in collagen-induced arthritis rats by inhibiting osteoclastogenesis via spleen tyrosine kinase","volume":"32","author":"Jia","year":"2018","journal-title":"FASEB J"},{"key":"2026090812140220800_ref24","doi-asserted-by":"crossref","first-page":"e14022","DOI":"10.1111\/jfbc.14022","article-title":"Antcin K inhibits VEGF-dependent angiogenesis in human rheumatoid arthritis synovial fibroblasts","volume":"46","author":"Achudhan","year":"2022","journal-title":"J Food Biochem"},{"key":"2026090812140220800_ref25","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"A","year":"2023","journal-title":"Lancet"},{"key":"2026090812140220800_ref26","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/art.27503","article-title":"Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis?","volume":"62","author":"Bevaart","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2026090812140220800_ref27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246275","article-title":"NAKATOMI C.NF-\u03baB Signaling regulates physiological and pathological chondrogenesis","volume":"20","author":"Jimi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026090812140220800_ref28","first-page":"1689","article-title":"Regulation of articular cavity fluid and serum IL-1\u03b2\uff0cIL-6 and TNF-\u03b1 by tetrandrine in collagen-induced arthritis rat model","volume":"11","author":"Pan","year":"2012","journal-title":"J Clin Experimental Med"},{"key":"2026090812140220800_ref29","doi-asserted-by":"crossref","first-page":"e14182","DOI":"10.1111\/jfbc.14182","article-title":"Resveratrol may ameliorate rheumatoid arthritis via the STAT3\/HIF-1\/VEGF molecular pathway","volume":"46","author":"Nazari-Khanamiri","year":"2022","journal-title":"J Food Biochem"},{"key":"2026090812140220800_ref30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijbiomac.2018.11.067","article-title":"Endogenous calcium attenuates the immunomodulatory activity of a polysaccharide from Lycium barbarum L. leaves by altering the global molecular conformation","volume":"123","author":"Zhang","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"2026090812140220800_ref31","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s10753-015-0129-x","article-title":"Pyrroloquinoline quinone slows down the progression of osteoarthritis by inhibiting nitric oxide production and metalloproteinase synthesis","volume":"38","author":"Tao","year":"2015","journal-title":"Inflammation"},{"key":"2026090812140220800_ref32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41374-020-0423-6","article-title":"Acidosis induces synovial fibroblasts to release vascular endothelial growth factor via acid-sensitive ion channel 1a","volume":"101","author":"Qian","year":"2021","journal-title":"Lab Investig"},{"key":"2026090812140220800_ref33","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijbiomac.2016.02.009","article-title":"Immunomodulatory and antioxidative activity of cordyceps militaris polysaccharides in mice","volume":"86","author":"Liu","year":"2016","journal-title":"Int J Biol Macromolecules: Struct Funct Interactions"},{"key":"2026090812140220800_ref34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAI.0000000000000335","article-title":"Intratumoral FOXP3+ regulatory T cells in diffuse large B-cell lymphoma","volume":"25","author":"Serag El-Dien","year":"2017","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2026090812140220800_ref35","doi-asserted-by":"crossref","first-page":"e2310456","DOI":"10.1002\/adma.202310456","article-title":"Platinum prodrug nanoparticles with COX-2 inhibition amplify Pyroptosis for enhanced chemotherapy and immune activation of pancreatic cancer","volume":"36","author":"Yu","year":"2024","journal-title":"Adv Mater"},{"key":"2026090812140220800_ref36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14397595.2017.1369491","article-title":"RANKL: A therapeutic target for bone destruction in rheumatoid arthritis","volume":"28","author":"Tanaka","year":"2018","journal-title":"Mod Rheumatol"},{"key":"2026090812140220800_ref37","first-page":"831","article-title":"Tetrandrine inhibits migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes through down-regulating the expressions of Rac1, Cdc42, and RhoA GTPases and activation of the PI3K\/Akt and JNK signaling pathways","volume":"13","author":"Lv","year":"2015","journal-title":"Chin J Nat Med"},{"key":"2026090812140220800_ref39","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1021\/acs.molpharmaceut.0c00295","article-title":"Nanomedicine for the treatment of Rheumatoid arthritis","volume":"18","author":"Jeong","year":"2021","journal-title":"Mol Pharm"},{"key":"2026090812140220800_ref40","doi-asserted-by":"crossref","first-page":"161943","DOI":"10.1155\/2013\/161943","article-title":"Enhanced topical delivery of tetrandrine by ethosomes for treatment of arthritis","volume":"2013","author":"Fan","year":"2013","journal-title":"Biomed Res Int"},{"key":"2026090812140220800_ref41","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17020169","article-title":"Pharmacokinetic and pharmacodynamic study of folic acid-modified chitosan-stearic acid Nanomicelles loaded with tetrandrine for Rheumatoid arthritis","volume":"17","author":"Ma","year":"2025","journal-title":"Pharmaceutics"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/8\/rgag083\/70634403\/rgag083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/78\/8\/rgag083\/70634403\/rgag083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:14:11Z","timestamp":1788884051000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/doi\/10.1093\/jpp\/rgag083\/8761094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgag083","relation":{},"ISSN":["2042-7158"],"issn-type":[{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8]]},"article-number":"rgag083"}}